World's Best Scientists 2026 revealed!
Marie-Lise Gougeon

Marie-Lise Gougeon

D-Index & Metrics

Immunology

D-Index
63
Citations
14945
World Ranking
3014
National Ranking
128

Marie-Lise Gougeon publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Marie-Lise Gougeon sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 210 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Marie-Lise Gougeon D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Marie-Lise Gougeon sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Marie-Lise Gougeon is affiliated with the Institut Pasteur in France and has contributed extensively to research in medicine and biochemistry, genetics, and molecular biology. Their work spans several subfields, including infectious diseases, epidemiology, public health, endocrine studies, and genetics.

The scientist has published research addressing a range of topics, notably:

  • Mosquito-borne diseases and control
  • Clostridium difficile and Clostridium perfringens research
  • Virus-based gene therapy research
  • Escherichia coli research studies
  • Viral gastroenteritis research and epidemiology
  • RNA regulation and disease
  • Herpesvirus infections and treatments

Frequent coauthors associated with their work include Béatrice Poirier-Beaudouin, Philippe Desprès, Cécile Artaud, Kumaran Deiva, and Jérôme Ausseil. These collaborations reflect continuity in research partnerships across different projects.

Their recent publications highlight a focus on immunology, gene therapy, and infectious diseases. Significant papers include:

  • Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study, 2020, The Lancet Infectious Diseases
  • Cell-Mediated Immunity to NAGLU Transgene Following Intracerebral Gene Therapy in Children With Mucopolysaccharidosis Type IIIB Syndrome, 2021, Frontiers in Immunology
  • Intracerebral Gene Therapy in Four Children with Sanfilippo B Syndrome: 5.5-Year Follow-Up Results, 2021, Human Gene Therapy
  • Zika Virus Inhibits IFN-α Response by Human Plasmacytoid Dendritic Cells and Induces NS1-Dependent Triggering of CD303 (BDCA-2) Signaling, 2020, Frontiers in Immunology
  • Does Clostridium Perfringens Epsilon Toxin Mimic an Auto-Antigen Involved in Multiple Sclerosis?, 2025, Toxins

The scientist's articles often appear in journals such as Frontiers in Immunology, médecine/sciences, The Lancet Infectious Diseases, Human Gene Therapy, and Toxins. This variety reflects engagement with both clinical and molecular aspects of infectious and genetic diseases.

Best Publications

  • Essential versus accessory aspects of cell death: recommendations of the NCCD 2015

    L. Galluzzi;J. M. Bravo-San Pedro;I. Vitale;S. A. Aaronson

  • Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis.

    P X Petit;H Lecoeur;E Zorn;C Dauguet

  • Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression.

    M L Gougeon;H Lecoeur;A Dulioust;M G Enouf

  • A Single Cycle of Rituximab for the Treatment of Severe Pemphigus

    Pascal Joly;Hugo Mouquet;Jean-Claude Roujeau;Michel D'Incan

  • Apoptosis in AIDS

    Marie-Lise Gougeon;Luc Montagnier

  • Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

    Abhishek D. Garg;Lorenzo Galluzzi;Lionel Apetoh;Lionel Apetoh;Thais Baert

  • MAIT cells detect and efficiently lyse bacterially-infected epithelial cells.

    Lionel Le Bourhis;Mathilde Dusseaux;Armelle Bohineust;Stéphanie Bessoles

  • Programmed cell death in AIDS-related HIV and SIV infections

    Marie-Lise Gougeon;Sylvie Garcia;Jonatnan Heeney;Roger Tschopp

  • Apoptosis as an HIV strategy to escape immune attack

    Marie-Lise Gougeon

  • A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity

    Hervé Lecoeur;Michèle Février;Sylvie Garcia;Yves Rivière

  • Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods.

    Hervé Lecoeur;Eric Ledru;Marie-Christine Prévost;Marie-Lise Gougeon

  • Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial.

    Marc Tardieu;Michel Zérah;Marie-Lise Gougeon;Jérome Ausseil

  • Staphylococcal Enterotoxin-Like Toxins U2 and V, Two New Staphylococcal Superantigens Arising from Recombination within the Enterotoxin Gene Cluster

    Damien Yann Thomas;Sophie Jarraud;Brigitte Lemercier;Gregoire Cozon

  • p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro

    Oliver Terradillos;Teresa Pollicino;Hervé Lecoeur;Marco Tripodi

  • A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection.

    Jean-Pierre de Villartay;Annick Lim;Hamoud Al-Mousa;Sophie Dupont

  • CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.

    Fabrizio Poccia;Barbara Cipriani;Silvia Vendetti;Vittorio Colizzi

  • Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus–associated lipodystrophy syndrome

    Eric Ledru;Névéna Christeff;Olivier Patey;Pierre de Truchis

  • Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection

    Claire Séror;Marie Thérèse Melki;Frédéric Subra;Syed Qasim Raza;Syed Qasim Raza

  • Peripheral V gamma 9/V delta 2 T cell deletion and anergy to nonpeptidic mycobacterial antigens in asymptomatic HIV-1-infected persons.

    F Poccia;S Boullier;H Lecoeur;M Cochet

  • Apoptosis associated with ex vivo down-regulation of Bcl-2 and up-regulation of Fas in potential cytotoxic CD8+ T lymphocytes during HIV infection.

    F Boudet;H Lecoeur;M L Gougeon

Frequent Co-Authors

Luc Montagnier
Luc Montagnier Institut Pasteur
Guido Kroemer
Guido Kroemer Université Paris Cité
Laurent Abel
Laurent Abel Université Paris Cité
Mauro Piacentini
Mauro Piacentini University of Rome Tor Vergata
Fabrice Carrat
Fabrice Carrat Sorbonne University
Jacques Thèze
Jacques Thèze Institut Pasteur
Vittorio Colizzi
Vittorio Colizzi University of Rome Tor Vergata
Jean-Jacques Fournié
Jean-Jacques Fournié Cancer Research Center of Toulouse
David M. Ojcius
David M. Ojcius University of the Pacific
Oliver Kepp
Oliver Kepp Institut Gustave Roussy

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related fields in healthcare can expand career opportunities. Many professionals choose to advance their education through nursing pathways. For instance, pursuing the cheapest psych np programs offers a budget-friendly route into psychiatric nursing, complementing immunological knowledge with mental health expertise.

Understanding the financial outlook is also important. Transparent information about salaries, such as the dnp salary transparency, helps prospective students gauge potential earnings and regional differences after completing a Doctor of Nursing Practice degree.

For those already working as Family Nurse Practitioners, advancing to specialized areas is possible through programs like the fnp to acnp bridge program online. This pathway enables nurses to transition into acute care, enhancing clinical skills that can be valuable in immunology-focused patient care.

Finally, accelerated programs such as the accelerated fnp programs provide a faster route to becoming a Family Nurse Practitioner. These options are ideal for students eager to enter the workforce quickly while building a strong foundation for specialized immunological roles.

Best Scientists Citing Marie-Lise Gougeon

Trending Scientists

Recently Published Articles